Shield Therapeutics Share Discussion Threads

[babbler] 24/5/2021 07:30

Get 2 months free via this link:https://get.readly.com/XxIYXUPtdgAOT2lt?source=android

[dandu69] 23/5/2021 16:23

Also from Shares magazine....

ELSEWHERE ON THE MARKET

Elsewhere, Shield Therapeutics (STX:AIM) rose 3.8% higher to 60p on news the specialty biotech remains ‘on track’ to launch iron deficiency drug Accrufer in the US by end of June 2021.

[kop202] 23/5/2021 13:28

krpI have access to Shares Mag and a whole host of other mags through a monthly sub to Readly. All online but sadly can't use hyper links

[purchaseatthetop] 23/5/2021 12:29

Dandu......the PATT Platter of ITX, AGL, STX, ENET and MCRO is a tasty offering for all discerning consumers of shares. I am certainly looking forward to a welcome boost on Monday. Last week was quite spectacular and next week looks like being the same.

[dandu69] 23/5/2021 11:04

Excellent coverage from shares magazine thanks for posting. Another little present for your PATT, along with press coverage of ITX aswell bodes well for more interest Monday I would suggest.

[purchaseatthetop] 23/5/2021 10:30

Still cannot believe the low market cap of STX considering they have now clarified their rollout plan for the USA. Anyway, keep on buying if you can. The chart is looking so strong.

Next week we should break 65p and then recent price levels of 40pish will look far in the past. All IMO and do not believe a word I write.

[krp10] 23/5/2021 10:05

Thank you Swizz

[swizz] 23/5/2021 09:47

Link to article,….GL S

[krp10] 23/5/2021 09:44

Can you please share that write up KoP202 ?
Thank you

[innittowinit] 23/5/2021 08:55

Re post 2169 - looks like my earlier thoughts were pretty much on the ball if you believe their key guy's apparent comments...

[kop202] 23/5/2021 00:35

Nice write up in Shares mag

[skcots48] 21/5/2021 17:12

I think you correctly assumed 2 tablets a day for a year or at least as long as they need their anaemia corrected or maintained. The 4 months is an estimate (guess) of usage per patient so they can estimate sales. It could be conservative based on many patients in the clinical study staying on drug for the full year.

[purchaseatthetop] 21/5/2021 16:24

Every share I pop into having a look at is inhabited by friends from other shares. Quite reassuring. Guru, dona, ketch, russ......when you think that STX nearly did a licensing deal which would have delivered a royalty of less than 1/5th of what the company will make now.

Brilliant.

[rimau1] 21/5/2021 16:09

Brian Groch replied directly intra day to my pricing question from this morning. The usage assumption per patient is on average 4 bottles per annum so $1000 net revenue per patient per annum to STX. Each bottle has 30 days supply and i wrongly assumed patients take 2 tablets every day all year.

[gurunostradamus] 21/5/2021 16:00

Added whilst we can under 60p levels!

[russ42] 21/5/2021 15:16

Kemche my old friend I bought in a while ago

[jackson83] 21/5/2021 15:13

they will need more funding later this year ?

[transhoneyqueens] 21/5/2021 15:03

its a 100 x bagger ... top up time

[cyberbub] 21/5/2021 14:57

There's bound to be resistance around 30p, the 100% profit mark from the placing. Won't last long, if the company delivers what it promises.

[kemche] 21/5/2021 14:41

russ, When did you buy in?

Cannot believe that I hold the same stock as you!

[russ42] 21/5/2021 14:06

Prepare for this board to be ruined as trash honey queen and multiple aliases has arrived. Best to filter

[donaferentes] 21/5/2021 14:00

I'm very good at gramanas!

[transhoneyqueens] 21/5/2021 13:44

some one sold 2 x 50k blocks

[gurunostradamus] 21/5/2021 12:56

What countdown PATT? Countdown to you becoming a multi millionaire in ITX!

[purchaseatthetop] 21/5/2021 12:49

now I know who not to invite onto Countdown......